Oregon

A joint statement from Kaiser Permanente, Legacy Health, OHSU Health and Providence

Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.

As of Monday, Nov. 7, Providence Oregon has stopped requiring pre-procedure COVID testing of asymptomatic surgical patients. See the details and a review of recent studies supporting the change.

Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.

Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.

To protect vulnerable Oregonians, Legacy Health, PeaceHealth and Providence are coming together to ensure OHA provides adequate mental health treatment capacity for civilly committed individuals.

Leading lung cancer professionals to gather in November for premier oncology summit.

Providence’s team of certified nursing assistants use technology to keep some of our most vulnerable patients safe, 24 hours a day, without ever stepping foot inside their rooms.

Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.

New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.

Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.

New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer

Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.

Basic social needs are important for health, including access to food, shelter and transportation. In Oregon and Washington, partnerships with Impact NW and CHAS help Providence patients.

Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.

Providence’s forensic nurse examiner team care for some of our most vulnerable patients in their most desperate times. See all they do and why they do it.

Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

When we talk about how Providence helps others, you might think first of health care for patients. But there are many more ways we support people in our communities.